GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Digicann Ventures Inc (XCNQ:DCNN) » Definitions » EV-to-EBITDA

Digicann Ventures (XCNQ:DCNN) EV-to-EBITDA : 0.07 (As of May. 20, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Digicann Ventures EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Digicann Ventures's enterprise value is C$1.17 Mil. Digicann Ventures's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was C$16.88 Mil. Therefore, Digicann Ventures's EV-to-EBITDA for today is 0.07.

The historical rank and industry rank for Digicann Ventures's EV-to-EBITDA or its related term are showing as below:

XCNQ:DCNN' s EV-to-EBITDA Range Over the Past 10 Years
Min: -82.54   Med: -1.25   Max: 3.97
Current: 0.07

During the past 13 years, the highest EV-to-EBITDA of Digicann Ventures was 3.97. The lowest was -82.54. And the median was -1.25.

XCNQ:DCNN's EV-to-EBITDA is ranked better than
98.45% of 710 companies
in the Drug Manufacturers industry
Industry Median: 14.875 vs XCNQ:DCNN: 0.07

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-20), Digicann Ventures's stock price is C$0.035. Digicann Ventures's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was C$1.487. Therefore, Digicann Ventures's PE Ratio for today is 0.02.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Digicann Ventures EV-to-EBITDA Historical Data

The historical data trend for Digicann Ventures's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Digicann Ventures EV-to-EBITDA Chart

Digicann Ventures Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.20 -0.77 3.28 -1.10 0.03

Digicann Ventures Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.10 -0.92 -1.07 -1.08 0.03

Competitive Comparison of Digicann Ventures's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Digicann Ventures's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Digicann Ventures's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Digicann Ventures's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Digicann Ventures's EV-to-EBITDA falls into.



Digicann Ventures EV-to-EBITDA Calculation

Digicann Ventures's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=1.168/16.881
=0.07

Digicann Ventures's current Enterprise Value is C$1.17 Mil.
Digicann Ventures's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$16.88 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Digicann Ventures  (XCNQ:DCNN) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Digicann Ventures's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.035/1.487
=0.02

Digicann Ventures's share price for today is C$0.035.
Digicann Ventures's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$1.487.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Digicann Ventures EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Digicann Ventures's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Digicann Ventures (XCNQ:DCNN) Business Description

Traded in Other Exchanges
Address
789 West Pender Street, Suite 810, Vancouver, BC, CAN, V6C1H2
Digicann Ventures Inc Formerly Agra Ventures Ltd is a pharmaceutical company engaged in the sale of cannabis-related products. The company's geographic segment includes Germany and Canada, with the majority of sales coming from Germany.
Executives
Nicholas Jonathan Kuzyk Director, Senior Officer

Digicann Ventures (XCNQ:DCNN) Headlines

No Headlines